BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10398110)

  • 1. Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies.
    Sasaki S; Bao Q; Hughes RC
    J Pathol; 1999 Mar; 187(4):481-9. PubMed ID: 10398110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
    Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
    Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis.
    Nikolic-Paterson DJ; Jun Z; Tesch GH; Lan HY; Foti R; Atkins RC
    J Am Soc Nephrol; 1996 Jul; 7(7):1006-14. PubMed ID: 8829115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.
    Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR
    Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis.
    Jyo-Oshiro Y; Sasaki T; Kawakami Y; Nohno T; Itoh N; Osawa G; Kashihara N
    Virchows Arch; 1999 Nov; 435(5):501-8. PubMed ID: 10592054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.
    Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ
    J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-alpha1 integrin subunit antibody on anti-Thy-1 glomerulonephritis.
    Kagami S; Urushihara M; Kondo S; Hayashi T; Yamano H; Löster K; Vossmeyer D; Reutter W; Kuroda Y
    Lab Invest; 2002 Sep; 82(9):1219-27. PubMed ID: 12218083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
    Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
    Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
    Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
    Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
    Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.